Practical value of the new system for Maspin assessment, in colorectal cancer

Neoplasma

Volumn 60, Issue 4, 2013, Pages 373-383

  Gurzu, S ^a   Szentirmay, Z ^b   Popa, D ^b   Jung, I ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Bax; CD31; Colorectal cancer; Maspin

Indexed keywords

CD31 ANTIGEN; MASPIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VASCULOTROPIN; MICROSATELLITE DNA; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5;

ADENOCARCINOMA; ADULT; ANGIOGENESIS; ARTICLE; CAPILLARY DENSITY; CELL BUDDING; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SURVIVAL RATE; AGED; APOPTOSIS; CHEMISTRY; COLORECTAL TUMOR; GENETICS; MULTIVARIATE ANALYSIS; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; APOPTOSIS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; SERPINS; TUMOR SUPPRESSOR PROTEIN P53;

MLCS; MLOWN;

EID: 84879177504     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_049     Document Type: Article

References (27)

1. RAVENHILL L, WAGSTAFF L, EDWARDS DR, ELLIS V, BASS R G-helix of Maspin Mediates Effects on Cell Migration and Adhesions. J Biol Chem 2010; 285: 36285-36292. http://dx.doi.org/10.1074/jbc.M110.177253
2. ZOU Z, ANISOWICZ A, HENDRIX MJC, THOR A, NEVEU M et al. Maspin: A Serpin with tumor suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-529. http://dx.doi.org/10.1126/science.8290962
3. SHAO ZM, NGUYEN M, ALPAUGH ML, O'CONNELL JT, BARSKY SH The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21waf1/cip1 induction, G2/M arrest and apoptosis. Exp Cell Res 1998; 241: 394-403. http://dx.doi.org/10.1006/excr.1998.4066
4. QIN L, ZHANG M Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway. J Biol Chem 2010; 285: 32360-32369. http://dx.doi.org/10.1074/jbc.M110.131045
5. LI Z, SHI HY, ZHANG M Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 2005; 24: 2008-2019. http://dx.doi.org/10.1038/sj.onc.1208449
6. IMPAGNATIELLO MA, BIANCHI E, DI STEFANO R, PARDI R, MOSCA F A novel approach to identification of genes involved in neo-angiogenesis: implication for graft revascularization. Transplant Proc 1997; 29: 1110. http://dx.doi.org/10.1016/S0041-1345(96)00450-2
7. DIETMAIER W, BETTSTETTER M, WILD PJ, WOENCKHAUS M, RUMMELE P et al. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer 2005; 118: 2247-2254. http://dx.doi.org/10.1002/ijc.21620
8. WOENCKHAUS M, BUBENDORF L, DALQUEN P, FOERSTER J, BLASZYK H et al. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer. J Clin Pathol 2007; 60: 483-486. http://dx.doi.org/10.1136/jcp.2005.033407
9. UMEKITA Y, OHI Y, SAGARA Y, YOSHIDA H. Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 2002; 100: 452-455. http://dx.doi.org/10.1002/ijc.10500
10. REIS-FILHO JS, TORIO B, ALBERGARIA A, SCHMITT FC Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 2002; 441: 551-558. http://dx.doi.org/10.1007/s00428-002-0710-1
11. UMEKITA Y, SOUDA M, YOSHIDA H Expression of maspin in colorectal cancer. In vivo 2006; 20: 797-800.
12. ZHENG H, TSUNEYAMA K, CHENG C, HIROYUKI T, ZHENGGUO C et al. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 2007; 27: 259-266.
13. UENO H, MURPHY J, JASS JR, MOCHIZUKI H, TALBOT IC. Tumor, budding' as an index to estimate the potential of agressiveness in rectal cancer. Histopathology 2002; 40: 127-132. http://dx.doi.org/10.1046/j.1365-2559.2002.01324.x
14. JANAVICIUS R, MATIUKAITE D, JAKUBAUSKAS A, GRISKEVICIUS L Microsatellite instability detection by High-Resolution Melting analysis. Clin Chem 2010; 56: 1750-1757. http://dx.doi.org/10.1373/clinchem.2010.150680
15. DIETMAIER W, WALLINGER S, BOCKER T, KULLMANN F, FISHEL R, RUSCHOFF J Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57: 4749-4756.
16. COHEN J Weighted kappa: nominal scale agreement with provision for scale disagreement or partial credit. Psychol Bull 1968; 70: 213-230. http://dx.doi.org/10.1037/h0026256
17. BERNARDO MM, MENG Y, LOCKETT J, DYSON G, DOMGOWSKY A et al. Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation. Genes Cancer 2011; 2: 1009-1022. http://dx.doi.org/10.1177/1947601912440170
18. BAILEY CM, KHALKHALI-ELLIS Z, SEFTOR EA, HENDRIX MJ. Biological functions of maspin. J Cell Physiol 2006; 209: 617-624. http://dx.doi.org/10.1002/jcp.20782
19. LOCKETT J, YIN S, LI X, MENG Y, SHENG S Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 2006; 97: 651-660. http://dx.doi.org/10.1002/jcb.20721
20. SOOD AK, FLETCHER MS, GRUMAN LM, COFFIN JE, JABBARI S et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002; 8: 2924-2932.
21. YU M, ZHENG H, TSUNEYAMA K, TAKAHASHI H, NOMOTO K et al. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 2007; 238: 1248-1255. http://dx.doi.org/10.1016/j.humpath.2006.11.025
22. SONG SY, LEE SK, KIM DH, SON HE, KIM HJ, et al. Expression of maspin in colon cancers. Its relationship with p53 expression and microvessel density. Digest Dis Sci 2002; 47: 1831-1835. http://dx.doi.org/10.1023/A:1016409031562
23. YILMAZ M, CHRISTOFORI G Mechanism of motility in metastasizing cells. Mol Cancer Res 2010; 8: 629-642. http://dx.doi.org/10.1158/1541-7786.MCR-10-0139
24. CAO D, WILENTZ RE, ABBRUZZESE JL, HO L, MAITRA A. Aberrant expression of Maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer 2005; 36: 39-46. http://dx.doi.org/10.1385/IJGC:36:1:039
25. MARKL B, AMHOLDT HM, JAHNIG H, SCHENKIRSCH G, HERMANN RA et al. Shift to cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. Hum Pathol 2010; 41: 1024-1033. http://dx.doi.org/10.1016/j.humpath.2009.10.021
26. FUNG CL, CHAN C, JANKOVA L, DENT OF, ROBERTSON G et al. Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer. Histopathology 2010; 56: 319-330. http://dx.doi.org/10.1111/j.1365-2559.2010.03479.x
27. BOLTZE C. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 2005; 200: 783-790. http://dx.doi.org/10.1016/j.prp.2004.10.004